Name: COGENT BIOSCIENCES INC (COGT) Stock
Brand: COGENT BIOSCIENCES INC
Rating: 6.5 (3 reviews)

COGT Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Cogent Biosciences, Inc.

Cogent Biosciences Announces KRAS Poster Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

9 days ago - By: Cogent Biosciences, Inc.

Cogent Biosciences Announces FDA Breakthrough Therapy Designation for Bezuclastinib

a month ago - By: Cogent Biosciences, Inc.

Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Benzinga - Mentions: RZLV YDES URG ALKS ...

Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday

3 months ago - By: Cogent Biosciences, Inc.

Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results

3 months ago - By: Yahoo Finance - Mentions: GS

Cogent Biosciences Rated as a Buy at Citi on Robust Pipeline

3 months ago - By: Benzinga - Mentions: SPY OPEN QQQ QS

3 Stocks With Sky-High Overbought Signals: QuantumScape, Opendoor, Cogent Flash RSI Red Flags

3 months ago - By: Yahoo Finance

Jefferies Raises Cogent Biosciences (COGT) PT, Keeps Buy Rating

4 months ago - By: Cogent Biosciences, Inc.

Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

4 months ago - By: Stocktwits

Cogent Biosciences Scores Analyst Praise As Mastocytosis Drug Hits Trial Goals; Retail Buzz Surges

4 months ago - By: Cogent Biosciences, Inc.

Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock

4 months ago - By: Cogent Biosciences, Inc.

Cogent Biosciences Announces Proposed $150 Million Public Offering of Common Stock

4 months ago - By: Cogent Biosciences, Inc.

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis

5 months ago - By: Cogent Biosciences, Inc.

Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing

6 months ago - By: Zacks Investment Research

Wall Street Analysts Believe Cogent Biosciences (COGT) Could Rally 224.37%: Here's is How to Trade

6 months ago - By: Yahoo Finance - Mentions: DHI CMG

Why Cogent Biosciences (COGT) Is One of the Best Low Priced Biotech Stocks to Buy Now

6 months ago - By: Cogent Biosciences, Inc.

Cogent Biosciences Reports First Quarter 2025 Financial Results

6 months ago - By: Yahoo Finance - Mentions: SAN CRMT DZZ BUD ...

Is Banco Santander (SAN) The Best Performing Large Cap Stock So Far in 2025?

6 months ago - By: Yahoo Finance - Mentions: SKX JANX EWTX BCYC ...

State Street Report Shows Big Slump in April ETF Inflows

6 months ago - By: Yahoo Finance - Mentions: DHI CMG

Is Cogent Biosciences, Inc. (COGT) the Best Small Cap Stock to Buy with the Biggest Upside Potential?

6 months ago - By: Cogent Biosciences, Inc.

Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders

6 months ago - By: Yahoo Finance - Mentions: MS META AMZN CRM ...

Meta Platforms, Inc. (META) Leans on AI Strength as Growth Forecast Slips

6 months ago - By: Yahoo Finance - Mentions: IVZ RLAY MS META ...

Relay Therapeutics (RLAY): The Most Promising Penny Stock According to Analysts

6 months ago - By: Yahoo Finance - Mentions: IVZ MS

Cogent Biosciences (COGT): Among the Most Promising Penny Stocks According to Analysts

7 months ago - By: Yahoo Finance - Mentions: PLTR AAPL USB

Is Cogent Biosciences Inc. (NASDAQ:COGT) the Best Biotech Penny Stock to Buy According to Hedge Funds?

7 months ago - By: Cogent Biosciences, Inc.

COGENT BIOSCIENCES INC (COGT) Stock News

COGT Latest News, Press Relases and Analysis

Cogent Biosciences Announces KRAS Poster Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Cogent Biosciences Announces FDA Breakthrough Therapy Designation for Bezuclastinib

Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday

Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results

Cogent Biosciences Rated as a Buy at Citi on Robust Pipeline

3 Stocks With Sky-High Overbought Signals: QuantumScape, Opendoor, Cogent Flash RSI Red Flags

Jefferies Raises Cogent Biosciences (COGT) PT, Keeps Buy Rating

Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Cogent Biosciences Scores Analyst Praise As Mastocytosis Drug Hits Trial Goals; Retail Buzz Surges

Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock

Cogent Biosciences Announces Proposed $150 Million Public Offering of Common Stock

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis

Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing

Wall Street Analysts Believe Cogent Biosciences (COGT) Could Rally 224.37%: Here's is How to Trade

Why Cogent Biosciences (COGT) Is One of the Best Low Priced Biotech Stocks to Buy Now

Cogent Biosciences Reports First Quarter 2025 Financial Results

Is Banco Santander (SAN) The Best Performing Large Cap Stock So Far in 2025?

State Street Report Shows Big Slump in April ETF Inflows

Is Cogent Biosciences, Inc. (COGT) the Best Small Cap Stock to Buy with the Biggest Upside Potential?

Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders

Meta Platforms, Inc. (META) Leans on AI Strength as Growth Forecast Slips

Relay Therapeutics (RLAY): The Most Promising Penny Stock According to Analysts

Cogent Biosciences (COGT): Among the Most Promising Penny Stocks According to Analysts

Is Cogent Biosciences Inc. (NASDAQ:COGT) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting